# CRISPR Therapeutics AG: Form 8-K, filed Feb 13, 2024

- Company: [CRISPR Therapeutics AG](/companies/crsp.md) (CIK 1674416)
- Form: 8-K
- Filed: 2024-02-13
- Accepted by EDGAR: Feb 13, 2024, 06:30 ET
- Period: 2024-02-13
- Accession: 0001193125-24-032825
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1674416/000119312524032825/d787773d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1674416/000119312524032825/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1674416/000119312524032825/d787773d8k.htm

Filed Feb 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-032825. Last ingested by Listed: Nov 10, 2026, 16:45 ET. No prices; not investment advice.